Mukhtar Kulimbet

Dr. Mukhtar Kulimbet

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2023 in Heliyon
Verified
Journal Article
Open access
NGNatalya Glushkova
Natalya Glushkova
AIAlexandr Ivankov
Alexandr Ivankov
VTVarvara Trenina
Varvara Trenina
AOAinash Oshibayeva
Ainash Oshibayeva
ZKZhanna Kalmatayeva
Zhanna Kalmatayeva
KMKerim Munir
Kerim Munir
In January 2022 Kazakhstan experienced unprecedented nationwide protests that quickly turned to violent riots. Although the number of individuals affected physically by the disturbances were cited, the emotional toll of the events remains undetermined. The aim of this study was to evaluate the comparative rates of acute stress reactions in Kazakhstan in the aftermath of the unrests. A cross-sectional, population-based online survey was conducted one month after the start of the disturbances. The study questionnaire were completed anonymously and included the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) and the General Anxiety Disorder-7 (GAD-7), as well as socio-demographic and event exposure information. Of the 7021 people who initially agreed to participate, 6510 were able to complete the full survey. For a cut-off of ≥3 on the PC-PTSD-5, 14.8 % of the study participants exhibited symptoms. With a cut-off of ≥4, this percentage reduced to 4.6 %. Participants from Almaty city and Almaty region who experienced the most extensive disturbances showed a doubled prevalence compared to the national level (30.0 % for a cut-off of ≥3, and 10.1 % for a cut-off of ≥4). At the national level, the prevalence of anxiety symptoms, defined as a score of ≥10 on the GAD-7, stood at 10.9 %. This prevalence decreased to 4.2 % when considering a cut-off of ≥15. Health authorities of riot-affected areas ought to be aware of the population level mental health impact of the civil conflict and consider provision of targeted interventions to mitigate the long-term consequence of these lifespan disorders, while also seeking for the peaceful resolution of the ensuing conflicts.

6 June 2025 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
ATAigerim Turekulova
Aigerim Turekulova
НДНуржамал Джардемалиева
Нуржамал Джардемалиева
AMAlibek Mereke
Alibek Mereke
Mukhtar KulimbetMukhtar Kulimbet
Mukhtar Kulimbet
Background/Objectives: Hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia, are leading causes of maternal morbidity and mortality worldwide and in Kazakhstan. This study aims to assess the burden of hypertensive disorders of pregnancy and main maternal disorders in Almaty, Kazakhstan, using the disability adjusted life years (DALY) methodology. Methods: We conducted a retrospective analysis of women aged 18 and above in Almaty, Kazakhstan, from 2018 to 2020. The medical claim data were retrieved from the Almaty city branch of the Republican Center for Electronic Health Care. Incidence-based DALY were calculated. Results: The total DALY increased for severe pre-eclampsia from 109.3 in 2018 to 187.2 in 2020 per 100,000 population and eclampsia from 3.1 in 2018 to 159.3 in 2020 per 100,000 population. Also, the 25–29 years age group had the largest increase in percent change (5.8) in the total DALY for hypertensive disorders of pregnancy. In addition, the 20–24 years age groups had the largest increase in percent change in the total DALY for severe pre-eclampsia (25.8) and eclampsia (80.5). Conclusions: Our findings highlight an increase in the burden of maternal disorders, especially for severe pre-eclampsia and eclampsia, in Almaty, Kazakhstan, from 2018 to 2020. Younger women bear a significant share of this burden, compounded by the pandemic’s impact on healthcare services.

DDDimash Davletov
Dimash Davletov
Mukhtar KulimbetMukhtar Kulimbet
Mukhtar Kulimbet
AMAlisher Makhmutov
Alisher Makhmutov
DODinmukhammed Osser
Dinmukhammed Osser
MPMarat Pashimov
Marat Pashimov
KDKairat Davletov
Kairat Davletov
Ischemic heart disease (IHD) remains a leading cause of death globally. This study aims to analyze the burden of IHD in Central Asia and in individual countries of the region from 1990 to 2021, through a comparison of trends in incidence, prevalence, mortality, and disability-adjusted life years. Using data from the Global Burden of Disease (GBD) 2021 study, we extracted annual estimates for the Central Asian region, Kazakhstan, Kyrgyzstan, Uzbekistan, Tajikistan, Turkmenistan, Georgia, Armenia, Azerbaijan, and Mongolia. Metrics were reported as age-standardized rates per 100,000 population. Temporal trends were quantified using Average Annual Percent Change based on joinpoint regression models. A stratification by sex and age groups was done. Central Asia consistently maintained a higher IHD burden than the global average. While global age-standardized incidence rates per 100,000 population fell, Central Asia’s rates per 100,000 population rose from 641.97 in 1990 to 801.56 in 2021. Age-standardized death rates per 100,000 population in the region peaked in the mid-1990s following the dissolution of the Soviet Union but decreased overall from 320.47 in 1990 to 265.51 in 2021. However, this remains significantly higher than the 2021 global rate per 100,000 population of 108.73. Uzbekistan exhibited the highest growth in prevalence and incidence rates per 100,000 population, while Georgia demonstrated the largest reduction in DALYs rates per 100,000 population. Men demonstrated a higher burden across most metrics, although the sex gap narrowed in older populations. Central Asia faces rising incidence rates of IHD and burden levels that far exceed global averages. The significant heterogeneity among countries suggests that region-wide generalizations are insufficient and highlights the critical need for targeted, country-specific prevention programs and health system interventions.

28 December 2023 in Наука и здравоохранение
Verified
Journal Article
Open access
КДК.к. Давлетов
К.к. Давлетов
ALA.R.M. Lyons
A.R.M. Lyons
NGNatalya Glushkova
Natalya Glushkova
Mukhtar KulimbetMukhtar Kulimbet
Mukhtar Kulimbet
KNKulman Nyssanbayeva
Kulman Nyssanbayeva
ИФИ.р. Фахрадиев
И.р. Фахрадиев
Актуальность. Семейная гиперхолестеринемия (СГ) представляет собой часто встречающееся генетическое заболевание, которое влияет на обмен холестерина и уровень липопротеинов низкой плотности (ХС-ЛПНП). В случае отсутствия лечения, повышенные уровни ХС-ЛПНП могут привести к развитию атеросклероза уже в раннем возрасте, существенно увеличивая риск возникновения сердечно-сосудистых заболеваний до их преждевременного возникновения. Цель исследования: Разработать и внедрить национальный регистр пациентов с диагнозом семейная гиперхолестеринемия с целью систематического мониторинга, эффективного лечения и профилактики сердечно-сосудистых осложнений, таких как инфаркты и инсульты. Также исследовать взаимосвязь между возрастом и полом пациентов с СГ, выявить генетические факторы, определить их распространенность в исследуемой группе, и затем применить полученные результаты в национальном масштабе, интегрировав их в практику здравоохранения. Материалы и методы. Дизайн исследования разработан согласно Международному регистру лиц с семейной гиперхолестеринемией. Заключение. Разработанный национальный регистр будет интегрирован в систему мирового регистра пациентов с семейной гиперхолестеринемией. Это обеспечит прозрачность и видимость масштабов СГ в Казахстане на глобальном уровне. Создание и внедрение регистра для учета пациентов с СГ будет способствовать улучшению качества медицинской помощи и снижению риска сердечно-сосудистых осложнений у пациентов с СГ внутри страны. Background:Familial hypercholesterolemia (FH) is a prevalent genetic disorder that impacts cholesterol metabolism and low-density lipoprotein (LDL-C) levels. In the absence of treatment, elevated LDL-C levels can precipitate the early onset of atherosclerosis, significantly heightening the risk of premature cardiovascular diseases. Aim of the Study:The primary objective of this study is to develop and implement a national registry for individuals diagnosed with familial hypercholesterolemia (FH). This registry aims to facilitate systematic monitoring, effective treatment, and the prevention of cardiovascular complications, including heart attacks and strokes. Furthermore, it seeks to explore correlations between patients' age and gender with FH, identify genetic factors, ascertain their prevalence within the study cohort, and subsequently apply the findings on a national scale, integrating them into healthcare practices. Materials and Methods: The study design was formulated in accordance with the International Registry of Familial Hypercholesterolemia (FH). Conclusion:The established national registry will be seamlessly integrated into the global registry system for patients with familial hypercholesterolemia (FH). This integration will enhance transparency and global awareness of the prevalence of FH in Kazakhstan. The creation and implementation of this registry will make substantial contributions to enhancing the quality of healthcare and mitigating the risk of cardiovascular complications among FH patients within the country. Өзектілігі. Отбасылық гиперхолестеринемия (ОГ)-холестерин алмасуына және төмен тығыздықтағы липопротеин (ТТЛП-ХС) деңгейіне әсер ететін жиі кездесетін генетикалық ауру. Емдеу болмаған жағдайда, ТТЛП-ХС деңгейінің жоғарылауы ерте жаста атеросклероздың дамуына әкелуі мүмкін, бұл олардың ерте пайда болуына дейін жүрек-қан тамырлары ауруларының қаупін едәуір арттырады. Зерттеудің мақсаты: инфаркт пен инсульт сияқты жүрек-қан тамырлары асқынуларын жүйелі бақылау, тиімді емдеу және алдын алу мақсатында отбасылық гиперхолестеринемия диагнозы қойылған науқастардың ұлттық тізілімін әзірлеу және енгізу. Сондай-ақ, ОГ пациенттерінің жасы мен жынысы арасындағы байланысты зерттеу, генетикалық факторларды анықтау, олардың зерттеу тобында таралуын анықтау, содан кейін нәтижелерді Денсаулық сақтау тәжірибесіне біріктіру арқылы ұлттық ауқымда қолдану. Материалдар мен әдістер. Зерттеу дизайны отбасылық...

Mukhtar KulimbetMukhtar Kulimbet
Mukhtar Kulimbet
NGNatalya Glushkova
Natalya Glushkova
BSBeth Snitz
Beth Snitz
RTRadmila Tsoy
Radmila Tsoy
SAShalkar Adambekov
Shalkar Adambekov
KDKairat Davletov
Kairat Davletov
Cognitive impairment in older adults is a major public concern for Kazakhstan’s aging population. We aimed to (1) administer a neuropsychological test battery (NTB) in domains relevant to aging-associated cognitive impairment in a sample of adults aged 60+ without dementia in Almaty, Kazakhstan; (2) investigate the associations between demographic factors and test performance; and (3) provide information on the distribution of NTB scores as preliminary local normative data relevant for this population. A cross-sectional evaluation of 276 participants aged 60+ in Almaty, Kazakhstan, was conducted using cognitive instruments including tests of memory, attention, language, executive functions, visuospatial abilities, and processing speed. Multiple linear regression analyses were used to examine the association of demographic factors with neuropsychological test performance. The results from the regression analysis showed that those who are younger, have more years of education, are women, and are of Russian ethnicity had significantly better performance. The current study illustrated (1) the feasibility of administering the NTB to older adults in the general population in Kazakhstan; (2) the preliminary local normative neuropsychological measures; and (3) their independent associations with age, education, gender, and ethnicity. The findings are a platform for future research on dementia and cognitive impairment in older adults in Kazakhstan.

13 December 2023 in Research Square
Verified
Preprint
Open access
PDF file
AMArailym Maikenova
Arailym Maikenova
ANAlexander Nersesov
Alexander Nersesov
EKElmira Kuantay
Elmira Kuantay
Mukhtar KulimbetMukhtar Kulimbet
Mukhtar Kulimbet
YYYerkezhan Yerlanova
Yerkezhan Yerlanova
YLYuliya Ligay
Yuliya Ligay
This study aims to identify the predictors of ineffectiveness in antiviral therapy for chronic hepatitis C (CHC) in Kazakhstan. The rising prevalence and mortality rates associated with CHC globally and within Kazakhstan underscore the need for effective antiviral treatment strategies. Despite the introduction of direct-acting antiviral agents (DAAs) with high cure rates, a subset of patients fails to achieve a sustained virological response (SVR). We conducted a multicenter retrospective matched case-control study across 13 regions of Kazakhstan, including 812 patients with CHC. The study involved patients registered in healthcare organizations who had received DAAs, focusing on those who did not reach SVR. Variables such as demographic characteristics, virological status, stage of liver disease, comorbidities, lifestyle factors, therapy regimen, and patient adherence were analyzed. Logistic regression analysis identified multiple factors associated with increased risk of non-response to therapy, including comorbid conditions like arterial hypertension, hepatocellular carcinoma, and lifestyle factors. The study highlights the complexity of CHC treatment in Kazakhstan, emphasizing the need for personalized treatment plans and addressing comorbid conditions and lifestyle factors. This research contributes to understanding the multifaceted nature of CHC treatment response and aids in optimizing therapeutic strategies in similar healthcare settings.